Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head ...

Head and neck cancers account for approximately 4% of all cancers in the United States. Men are more than twice as likely as women to develop these types of cancer, and individuals older than 50 ...

The study, "Survivorship Therapy needs after Radiotherapy for head and Neck cancer: surveying opportunities for Growth ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC).

Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...

Immutep's eftilagimod shows promising results in head and neck cancer, with a median overall survival of 17.6 months, significantly higher than what has been observed with other approaches.

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

For patients undergoing jaw reconstruction after surgery for head and neck cancer, computer-aided design and manufacturing (CAD/CAM) techniques can improve some key clinical outcomes, reports a study ...